Required CCSG Acknowledgement
The NCI requires that publications acknowledge the UPCI CCSG support, and they are tracking compliance. If a UPCI CCSG-supported Shared Facility provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):
"This project used the UPCI [insert name(s) of shared facility(ies)] that [is/are] supported in part by award P30CA047904."
Shared Facility Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the UPCI CCSG support.
At UPCI, Shared Resources play a key role in supporting cancer research by providing investigators with access to both cutting-edge and expensive technology and technical expertise while, at the same time, containing costs.
Animal Facility
Quality, humane animal care and services in compliance with legal and regulatory requirements, to support existing and future animal research programs at UPCI
Biobehavioral Medicine Facility*
High-quality laboratory services to assess biological changes associated with stress and other psychological and behavioral factors in health and disease
Biostatistics Facility
Statistical and computer-related expertise in design, execution, analysis, and reporting of cancer-related basic, translational, and clinical research studies
Cancer Biomarkers Facility
State-of-the-art genomics and proteomics instrumentation, faculty expertise, and collaborative consultation for the discovery and translation of clinically relevant molecular biomarkers
Cancer Informatics Services
Expertise in bioinformatics, honest broker services, patient registry data services, clinical trials information management, and tissue banking and pathology annotation and inventory control
Cell and Tissue Imaging Facility
Expertise in the design and implementation of experiments using microscopic techniques and image analysis, including interpretation of morphological data
Cell Culture and Cytogenetics Facility*
Cell culture services including cell line authentication, EBV transformation of lymphocytes, and classical and molecular cytogenetics services
Chemical Biology Facility
Identification, characterization, and optimization of unique chemical probes and potential anticancer compounds
Clinical Pharmacology Analytical Facility
Accessible, economical, comprehensive, and state-of-the-art pharmacology research services that support preclinical and clinical research programs at UPCI and medical institutions nationwide
Clinical Research Services
Facilitates the development, implementation, and completion of all UPCI clinical research studies
Cytometry Facility
Analytical and imaging cytometry and cell sorting, for rapid quantitation of a wide variety of cellular properties
Hematopoietic Stem Cell Laboratory*
Processing, cryopreservation, and assistance with the infusion of hematopoietic progenitor cell products and therapeutic T-cell products and translational development of novel stem cell products
Immunologic Monitoring and Cellular Products Laboratory
Therapeutic cell product generation, serial monitoring of immunologic functions in patients with cancer who are treated with biologic therapies, and banking of blood and tissues for patients on clinical protocols
In Vivo Imaging Facility
Expertise and state-of-the-art instrumentation for magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), and optical/ultrasound small animal imaging
Investigational Drug Services
Oversees all pharmacy procedures and processes for UPCI and clinical sites where UPCI-sponsored studies are implemented
Tissue and Research Pathology Services
Centralized support for tissue and biological specimen procurement, research histology, and clinical data annotation
Vector Core Facility
Provides viral and non-viral vectors, cell lines, reagents, protocols, and technical assistance to aid cancer researchers in studies involving gene and shRNA transduction
* non-CCSG resource
